Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 7Phase NA 4Phase EARLY_PHASE1 3Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Recruiting 33Active not recruiting 18Not yet recruiting 10Suspended 6Completed 6Terminated 4Withdrawn 3Enrolling by invitation 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1CNS 1

Conditions

Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

irinotecan sucrosofate 1Temozolomide 1Radiation 1Irinotecan 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × 30 days × Clear all
NCT04488224 2026-05-19

Nano-X IG

University of Sydney

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasms

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

SynerGene Therapeutics, Inc.

Phase EARLY_PHASE1 Withdrawn
CNS

Central Nervous System Neoplasms

NCT06708936 2026-05-08

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Kousai Bio Co., Ltd.

Phase EARLY_PHASE1 Withdrawn
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡